Exploring disease-specific metabolite signatures in hereditary angioedema patients

Adīne Kaņepa (Corresponding Author), Jingzhi Fan, Dmitrijs Rots, Annija Vaska, Laura Ansone, Monta Briviba, Janis Klovins, Nataļja Kurjāne, Kristaps Kļaviņš (Corresponding Author)

Research output: Contribution to journalArticlepeer-review

Abstract

Introduction: Hereditary angioedema (HAE) is a rare, life-threatening autosomal dominant genetic disorder caused by a deficient and/or dysfunctional C1 esterase inhibitor (C1-INH) (type 1 and type 2) leading to recurrent episodes of edema. This study aims to explore HAE patients' metabolomic profiles and identify novel potential diagnostic biomarkers for HAE. The study also examined distinguishing HAE from idiopathic angioedema (AE).

Methods: Blood plasma samples from 10 HAE (types 1/2) patients, 15 patients with idiopathic AE, and 20 healthy controls were collected in Latvia and analyzed using LC-MS based targeted metabolomics workflow. T-test and fold change calculation were used to identify metabolites with significant differences between diseases and control groups. ROC analysis was performed to evaluate metabolite based classification model.

Results: A total of 33 metabolites were detected and quantified. The results showed that isovalerylcarnitine, cystine, and hydroxyproline were the most significantly altered metabolites between the disease and control groups. Aspartic acid was identified as a significant metabolite that could differentiate between HAE and idiopathic AE. The mathematical combination of metabolites (hydroxyproline * cystine)/(creatinine * isovalerylcarnitine) was identified as the diagnosis signature for HAE. Furthermore, glycine/asparagine ratio could differentiate between HAE and idiopathic AE.

Conclusion: Our study identified isovalerylcarnitine, cystine, and hydroxyproline as potential biomarkers for HAE diagnosis. Identifying new biomarkers may offer enhanced prospects for accurate, timely, and economical diagnosis of HAE, as well as tailored treatment selection for optimal patient care.
Original languageEnglish
Article number1324671
JournalFrontiers in Immunology
Volume25
Issue number15
DOIs
Publication statusPublished - 2024

Keywords*

  • C1 inhibitor
  • biomarkers
  • diagnosis
  • Hereditary angioedema
  • Metabolome

Field of Science*

  • 3.1 Basic medicine
  • 3.3 Health sciences

Publication Type*

  • 1.1. Scientific article indexed in Web of Science and/or Scopus database

Fingerprint

Dive into the research topics of 'Exploring disease-specific metabolite signatures in hereditary angioedema patients'. Together they form a unique fingerprint.

Cite this